'The Federal Government Wants To Provide 10 Million Doses Of Novavax' - German Government "Presse Augsburg"
Portfolio Pulse from Benzinga Newsdesk
The German federal government plans to make approximately 10.6 million doses of Novavax's new corona vaccine available to citizens in the fourth quarter of 2023, subject to approval. The vaccine is adapted to the XBB.1.5 variant and is a protein-based preparation. Meanwhile, the delivery of the adapted Biontech vaccine has begun nationwide.
September 19, 2023 | 2:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Novavax's new corona vaccine is expected to be made available by the German government in Q4 2023, subject to approval. This could potentially increase the company's revenues and market presence in Germany.
The German government's plan to provide Novavax's new corona vaccine to its citizens could potentially increase the company's revenues and market presence in Germany. However, this is subject to the vaccine's approval and its effectiveness against the XBB.1.5 variant.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100